Evidence map›Paper›PMID 32958580›Full record

ArticleScience (New York, N.Y.)2020

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.

Christine Toelzer, Kapil Gupta, Sathish K N Yadav, Ufuk Borucu, Andrew D Davidson, Maia Kavanagh Williamson, Deborah K Shoemark, Frederic Garzoni, Oskar Staufer, Rachel Milligan and 6 more

Open access · hybridAbstract readVideo-Audio Media
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 278 papers.

0numbers the graph read from it
0cells of the map it votes in
278citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

278 citing papers in PubMed, 491 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. MarinePharmaceuticals (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

218 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Christine Toelzer *School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0001-9984-5940
Kapil Gupta *School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0002-2115-3503
Sathish K N Yadav *School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0003-0779-0941
Ufuk Borucu *School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0001-6746-5409
Andrew D DavidsonSchool of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, UK.ORCID 0000-0002-1136-4008
Maia Kavanagh WilliamsonSchool of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, UK.ORCID 0000-0002-4659-8613
Deborah K ShoemarkSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0002-1240-8463
Frederic GarzoniImophoron Ltd., St. Philips Central, Albert Rd., St. Philips, Bristol BS2 0XJ, UK.ORCID 0000-0001-9668-9348
Oskar StauferDepartment for Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120 Heidelberg, Germany.ORCID 0000-0002-8015-3132
Rachel MilliganSchool of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, UK.ORCID 0000-0001-8952-246X
Julien CapinSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0002-5929-2955
Adrian J MulhollandSchool of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, UK.ORCID 0000-0003-1015-4567
Joachim SpatzDepartment for Cellular Biophysics, Max Planck Institute for Medical Research, Jahnstraße 29, 69120 Heidelberg, Germany.
Daniel FitzgeraldGeneva Biotech Sàrl, Avenue de la Roseraie 64, 1205, Geneva, Switzerland.
Imre BergerSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK. cb14941@bristol.ac.uk imre.berger@bristol.ac.uk.ORCID 0000-0001-7518-9045
Christiane SchaffitzelSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK. cb14941@bristol.ac.uk imre.berger@bristol.ac.uk.ORCID 0000-0002-1516-9760
At Bristol · GBUniversity of Bristol · GBHeidelberg University · DEPhilips (United Kingdom) · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L01386X/1Medical Research Council MR/R020566/1Medical Research Council MR/V027506/1Wellcome Trust
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a global crisis. Key to SARS-CoV-2 therapeutic development is unraveling the mechanisms that drive high infectivity, broad tissue tropism, and severe pathology. Our 2.85-angstrom cryo-electron microscopy structure of SARS-CoV-2 spike (S) glycoprotein reveals that the receptor binding domains tightly bind the essential free fatty acid linoleic acid (LA) in three composite binding pockets. A similar pocket also appears to be present in the highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). LA binding stabilizes a locked S conformation, resulting in reduced angiotensin-converting enzyme 2 (ACE2) interaction in vitro

Indexed as

Amino Acid SequenceAngiotensin-Converting Enzyme 2AnimalsBetacoronavirusBinding SitesChlorocebus aethiopsCryoelectron MicroscopyHumansLinoleic AcidMiddle East Respiratory Syndrome CoronavirusModels, MolecularPeptidyl-Dipeptidase AProtein Interaction Domains and MotifsProtein Structure, TertiarySARS-CoV-2Severe acute respiratory syndrome-related coronavirusACE2 protein, humanAngiotensin-Converting Enzyme 2Linoleic AcidPeptidyl-Dipeptidase ASpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID32958580
PMCPMC8050947
OpenAlexW3087409770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.